Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
Single allele	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		Autistic disorder of childhood onset	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545173			15	23319712 - 28800324	545173	535437		
Single allele	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236373	15	23624148 - 28790734			236373	237928		
Single allele	ATP10A|CYFIP1|GABRA5|HERC2|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|OR4M2|OR4N4|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236372	15	20044342 - 28924405			236372	237927		
Single allele	ATP10A|CYFIP1|GOLGA6L1|GOLGA6L2|GOLGA6L6|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OR4M2|OR4N4|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236371	15	20306549 - 26208861			236371	237926		
NM_001323289.2(CDKL5):c.2579_2582dup (p.Leu862fs)	CDKL5	L862fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001075877	X	18646570 - 18646571	X	18628450 - 18628451	1075877	1065259		NC_000023.11:18628450:CCAGCC:CCAGCCAGCC
NM_001323289.2(CDKL5):c.1584dup (p.Ser529fs)	CDKL5	S529fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001072905	X	18622626 - 18622627	X	18604506 - 18604507	1072905	1065256		NC_000023.11:18604506:CC:CCC
NM_001323289.2(CDKL5):c.1053_1056dup (p.Leu353fs)	CDKL5	L353fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jun 28, 2020)	criteria provided, single submitter	VCV001072660	X	18622096 - 18622097	X	18603976 - 18603977	1072660	1065255		NC_000023.11:18603976:AGGC:AGGCAGGC
NC_000023.10:g.(?_18582587)_(18627700_?)dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV001070860	X	18582587 - 18627700			1070860	1058211		
NC_000023.10:g.(?_18525211)_(18528980_?)dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV001070859	X	18525211 - 18528980			1070859	1058209		
NM_001323289.2(CDKL5):c.2153-64_2153-5delinsG	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000971254	X	18631208 - 18631267	X	18613088 - 18613147	971254	960978		
NM_001323289.2(CDKL5):c.878dup (p.Asn293fs)	CDKL5	N293fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000970805	X	18616632 - 18616633	X	18598512 - 18598513	970805	959217		NC_000023.11:18598512:AA:AAA
NM_001323289.2(CDKL5):c.2682dup (p.Pro895fs)	CDKL5	P895fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000947226	X	18646675 - 18646676	X	18628555 - 18628556	947226	929639		NC_000023.11:18628555:A:AA
NM_001323289.2(CDKL5):c.2376+4dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000858055	X	18638088 - 18638089	X	18619968 - 18619969	858055	852483		NC_000023.11:18619968:AA:AAA
NM_001323289.2(CDKL5):c.2197_2204dup (p.Arg735fs)	CDKL5	R735fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000857515	X	18631314 - 18631315	X	18613194 - 18613195	857515	849864		NC_000023.11:18613194:GTCAACTAG:GTCAACTAGTCAACTAG
NM_001323289.2(CDKL5):c.877_881dup (p.His294fs)	CDKL5	H294fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000845526	X	18616632 - 18616633	X	18598512 - 18598513	845526	849859		NC_000023.11:18598512:AATCA:AATCAAATCA
NM_001323289.2(CDKL5):c.1485dup (p.Lys496fs)	CDKL5	K496fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000838071	X	18622527 - 18622528	X	18604407 - 18604408	838071	849861		NC_000023.11:18604407:CC:CCC
NM_001323289.2(CDKL5):c.2682_2683insGGAA (p.Pro895fs)	CDKL5	P895fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000573189	X	18646675 - 18646676	X	18628555 - 18628556	573189	574440	rs1569225454	NC_000023.11:18628555:A:AGGAA
NM_001323289.2(CDKL5):c.614_617dup (p.Asp206fs)	CDKL5	D206fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000533389	X	18606131 - 18606132	X	18588011 - 18588012	533389	535119	rs1555950465	NC_000023.11:18588011:AGCGA:AGCGAGCGA
NC_000023.10:g.(?_18525055)_(18528974_?)dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000417421	X	18525055 - 18528974	X	18506935 - 18510854	417421	403990		
NC_000023.10:g.(?_17393881)_(20284750_?)dup	EIF1AX|NHS|PDHA1|PHKA2|PPEF1|RPS6KA3|RS1|SCML1|CDKL5|ADGRG2|SCML2|RAI2|SH3KBP1|BEND2|BCLAF3|MAP7D2|MAP3K15		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001041824	X	17393881 - 20284750			1041824	1022436		
NC_000023.10:g.(?_135080257)_(135292184_?)dup	FHL1|SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001036230	X	135080257 - 135292184			1036230	1022433		
NM_005249.5(FOXG1):c.177_186dup (p.Pro63fs)	FOXG1	P63fs	FOXG1 disorder|not provided|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000451937	14	29236655 - 29236656	14	28767449 - 28767450	451937	445223	rs1555321206	NC_000014.9:28767449:CCCGCCGCCGCCCGCC:CCCGCCGCCGCCCGCCGCCGCCCGCC
NM_005249.5(FOXG1):c.460dup (p.Glu154fs)	FOXG1	E154fs	not provided|FOXG1 disorder|Rett syndrome, congenital variant|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000095268	14	29236938 - 29236939	14	28767732 - 28767733	95268	101167	rs398124204	NC_000014.9:28767732:GGGGGGG:GGGGGGGG
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666599	15	23810928 - 28544664			666599	654159		
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545172			15	23319712 - 28684313	545172	535436		
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545171			15	23157975 - 28774125	545171	535435		
Single allele	GOLGA8S|GOLGA8T|LOC645202|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-12|SNORD115-13|MIR4509-3|MIR4715|SNORD107|SNORD109A|SNORD109B|SNORD115-1|SNORD108|SNORD115-10|SNORD115-11|LINC02250|LINC02346|LINC02352|HERC2|IPW|KLF13|LOC100996413|LINC00929|LINC02249|LOC100130111|LOC100132202|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC102723623|CYFIP1|FAM189A1|FAN1|PWRN2|PWRN3|PWRN4|SNHG14|APBA2|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|CHRFAM7A|CHRNA7|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8Q|GOLGA8R|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC283683|LOC283710|MAGEL2|MIR211|MIR4508|MIR4509-1|MIR4509-2|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|PWRN1|OTUD7A|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|TUBGCP5|UBE3A		Autistic disorder of childhood onset	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545163			15	22420897 - 32130343	545163	535427		
NM_014795.4(ZEB2):c.592+6_592+7delinsAA	LOC111721705|ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001035651	2	145162396 - 145162397	2	144404829 - 144404830	1035651	1023705		NC_000002.12:144404828:GC:TT
NM_014795.4(ZEB2):c.553_554insTG (p.Arg185fs)	LOC111721705|ZEB2	R161fs, R185fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004761	2	145162441 - 145162442	2	144404874 - 144404875	4761	19800	rs587776608	NC_000002.12:144404874::CA
NC_000023.10:g.(?_153287264)_(153363188_?)dup	MECP2		Mental retardation, X-linked, syndromic 13|Rett syndrome|Angelman syndrome	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000417368	X	153287264 - 153363188			417368	404014		
NC_000023.10:g.(?_17393861)_(18671684_?)dup	NHS|RS1|SCML1|CDKL5|SCML2|RAI2|BEND2		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000832827	X	17393861 - 18671684			832827	821495		
Single allele	PWAR4|LOC645202|SNORD115-1|GOLGA8S|APBA2|GABRA5|PWAR5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|SNURF|CYFIP1|FAM189A1|NPAP1|LINC02249|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-6|SNORD115-7|MAGEL2|NSMCE3|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|GOLGA6L1|GOLGA8J|GOLGA8T|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|LOC112272579|LOC112272580|GOLGA8G|SNORD108|LOC112272581|GOLGA6L7|SNORD116-20|SNORD116-21|SNORD115-17|SNORD115-18|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|ATP10A-DT|LOC112272575|LOC112272578|CHRFAM7A|HERC2|SNORD107|LOC100132202|LOC102723623|SNHG14|SNORD115-3|SNORD115-4|SNORD115-5|SNORD109B|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-24|SNORD116-25|MIR4508|MIR4509-3|MIR4509-2|MIR4715|SNORD116-30|SNORD115-46|GOLGA8F|TRE-TTC2-2|PWRN4|SNORD115-19|SNORD115-20|SNORD115-41|SNORD115-42|SNORD115-43|PWAR6|SNORD116-7|SNORD115-44|SNORD116-28|PWRN3|GABRG3-AS1|MIR4509-1|SNORD109A|LINC02250|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|PWRN1|PWRN2|SNORD115-21|SNORD115-22|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-23|SNORD115-25|SNORD115-26|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD115-34|SNORD115-35|SNORD116-22|SNORD116-23|SNORD64|PWARSN|LINC00929		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001098669			15	22804175 - 30375696	1098669	1087289		
Single allele	PWAR4|SNORD115-1|PWAR1|ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|OCA2|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236370	15	25334522 - 28369712			236370	237925		
NC_000015.10:g.(?_24566038)_(25781223_?)dup	PWAR5|UBE3A|IPW|PWAR6|SNRPN|SNORD116-1|PWAR1|PWARSN|PWAR4|ATP10A|SNORD115-1|NPAP1|PWRN1|SNURF		Angelman syndrome	Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000832161	15	24811185 - 26026370			832161	820665		
NC_000023.10:g.(?_18442725)_(18672749_?)dup	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001054292	X	18442725 - 18672749			1054292	1039259		
NC_000023.10:g.(?_18525053)_(18665462_?)dup	RS1|CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001015177	X	18525053 - 18665462			1015177	1001920		
NC_000023.10:g.(?_18668510)_(18668732_?)dup	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 30, 2020)	criteria provided, single submitter	VCV001007430	X	18668510 - 18668732			1007430	986706		
NC_000023.11:g.(?_18564457)_(18653564_?)dup	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000831636	X	18582577 - 18671684			831636	821574		
NM_001379110.1(SLC9A6):c.448-9_448-8insC	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV001146037	X	135080632 - 135080633	X	135998473 - 135998474	1146037	1150434		NC_000023.11:135998473::C
NM_001379110.1(SLC9A6):c.448-8_448-7insG	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001102761	X	135080633 - 135080634	X	135998474 - 135998475	1102761	1108022		NC_000023.11:135998474::G
NC_000023.11:g.(?_135985483)_(136024503_?)dup	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831697	X	135067642 - 135106662			831697	821559		
NM_001379110.1(SLC9A6):c.1080+80dup	SLC9A6		not provided|Christianson syndrome	Benign/Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804088	X	135095664 - 135095665	X	136013505 - 136013506	804088	792125	rs35492327	NC_000023.11:136013505:AAAAAAAAAAAA:AAAAAAAAAAAAA
NM_001379110.1(SLC9A6):c.447+3_447+4delinsCC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011478	X	135080347 - 135080348	X	135998188 - 135998189	11478	26517	rs730882187	NC_000023.11:135998187:AA:CC
NM_130839.5(UBE3A):c.2515_2531dup (p.Leu846fs)	SNHG14|UBE3A	L409fs, L429fs, L771fs, L774fs, L787fs, L794fs, L826fs, L846fs, L849fs	Angelman syndrome	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001073548	15	25584371 - 25584372	15	25339224 - 25339225	1073548	1063216		NC_000015.10:25339224:AGCACATTAAAGCAAGTA:AGCACATTAAAGCAAGTAGCACATTAAAGCAAGTA
NC_000015.9:g.(?_25584264)_(25620930_?)dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000583426	15	25584264 - 25620930	15	25339117 - 25375783	583426	568557		
NM_130839.5(UBE3A):c.1678_1699delinsT (p.Gln560_Val567delinsPhe)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000571267	15	25605584 - 25605605	15	25360437 - 25360458	571267	569216	rs1566912450	NC_000015.10:25360436:CACCTCCCTCATCAACTCCTTG:A
NM_130839.5(UBE3A):c.2355-6_2355-5insTAAT	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000528368	15	25585380 - 25585381	15	25340233 - 25340234	528368	528969	rs1555380917	NC_000015.10:25340233::ATTA
NC_000015.9:g.(?_25584264)_(25654274_?)dup	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000458664			15	25339117 - 25409127	458664	464765		
NC_000015.9:g.(?_25582396)_(25650653_?)dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000417431	15	25582396 - 25650653	15	25337249 - 25405506	417431	400846		
NM_130839.5(UBE3A):c.2607dup (p.Gly870fs)	SNHG14|UBE3A	G795fs, G818fs, G870fs, G433fs, G453fs, G798fs, G850fs, G873fs, G811fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212536	15	25584295 - 25584296	15	25339148 - 25339149	212536	208160	rs797046088	NC_000015.10:25339148:AAA:AAAA
NM_130839.5(UBE3A):c.2563_2567dup (p.Lys856fs)	SNHG14|UBE3A	K419fs, K804fs, K781fs, K784fs, K856fs, K859fs, K439fs, K836fs, K797fs	Angelman syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212535	15	25584335 - 25584336	15	25339188 - 25339189	212535	208161	rs1555379800	NC_000015.10:25339188:TTAAGTT:TTAAGTTAAGTT
NM_130839.5(UBE3A):c.2562dup (p.Leu855fs)	SNHG14|UBE3A	L418fs, L783fs, L796fs, L835fs, L438fs, L803fs, L855fs, L780fs, L858fs	Angelman syndrome	Pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000212534	15	25584340 - 25584341	15	25339193 - 25339194	212534	208163	rs797046087	NC_000015.10:25339193:TTTTT:TTTTTT
NM_130839.5(UBE3A):c.2523_2566dup (p.Lys856fs)	SNHG14|UBE3A	K781fs, K856fs, K859fs, K419fs, K784fs, K797fs, K836fs, K439fs, K804fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212533	15	25584336 - 25584337	15	25339189 - 25339190	212533	208162	rs587781230	NC_000015.10:25339189:TAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTA:TAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTATAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTA
NM_130839.5(UBE3A):c.2397_2400dup (p.Leu801fs)	SNHG14|UBE3A	L726fs, L742fs, L364fs, L781fs, L384fs, L729fs, L749fs, L804fs, L801fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212532	15	25585329 - 25585330	15	25340182 - 25340183	212532	208164	rs797046086	NC_000015.10:25340182:TCTTT:TCTTTCTTT
NM_130839.5(UBE3A):c.2238dup (p.Phe747fs)	SNHG14|UBE3A	F672fs, F310fs, F330fs, F747fs, F750fs, F688fs, F727fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212531	15	25599716 - 25599717	15	25354569 - 25354570	212531	208165	rs797046085	NC_000015.10:25354569:T:TT
NM_130839.5(UBE3A):c.62+1_62+2insAA	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212530	15	25650606 - 25650607	15	25405459 - 25405460	212530	208169	rs797046084	NC_000015.10:25405459::TT
NM_130839.5(UBE3A):c.2499-37dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156127	15	25584440 - 25584441	15	25339293 - 25339294	156127	165927	rs587782913	NC_000015.10:25339293:T:TT
NM_130839.5(UBE3A):c.2547_2567dup (p.Lys856_Glu857insAsnSerSerLysGluLysLeu)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155993	15	25584335 - 25584336	15	25339188 - 25339189	155993	165797	rs587781240	NC_000015.10:25339188:TTAAGTTTTTCTTTGCTTGAGT:TTAAGTTTTTCTTTGCTTGAGTTAAGTTTTTCTTTGCTTGAGT
NM_130839.5(UBE3A):c.2563_2566dup (p.Lys856delinsThrTer)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155983	15	25584336 - 25584337	15	25339189 - 25339190	155983	165787	rs398124440	NC_000015.10:25339189:TAAGT:TAAGTAAGT
NM_130839.5(UBE3A):c.2557_2560dup (p.Lys854fs)	SNHG14|UBE3A	K437fs, K779fs, K854fs, K795fs, K834fs, K857fs, K417fs, K782fs, K802fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155982	15	25584342 - 25584343	15	25339195 - 25339196	155982	165786	rs587781229	NC_000015.10:25339195:TTTCTTT:TTTCTTTCTTT
NM_130839.5(UBE3A):c.2523_2581dup (p.Lys861delinsIleMetCysPheTyrPheArgAsnThrGlnAlaLysLysAsnLeuLysArgAspCysTer)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155977	15	25584321 - 25584322	15	25339174 - 25339175	155977	165781	rs1555379745	
NM_130839.5(UBE3A):c.2349dup (p.Ile784fs)	SNHG14|UBE3A	I347fs, I709fs, I725fs, I764fs, I732fs, I787fs, I367fs, I712fs, I784fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155974	15	25599504 - 25599505	15	25354357 - 25354358	155974	165778	rs587781223	NC_000015.10:25354357:C:CC
NM_130839.5(UBE3A):c.2307_2311dup (p.Thr771fs)	SNHG14|UBE3A	T719fs, T771fs, T334fs, T354fs, T696fs, T699fs, T712fs, T751fs, T774fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155973	15	25599542 - 25599543	15	25354395 - 25354396	155973	165777	rs587781222	NC_000015.10:25354395:TAGTTT:TAGTTTAGTTT
NM_130839.5(UBE3A):c.2230_2234dup (p.Tyr745Ter)	SNHG14|UBE3A	Y328*, Y725*, Y745*, Y748*, Y308*, Y670*, Y686*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155967	15	25599720 - 25599721	15	25354573 - 25354574	155967	165771	rs587781216	NC_000015.10:25354573:TACTTTA:TACTTTACTTTA
NM_130839.5(UBE3A):c.2162_2163insTATT (p.Lys721fs)	SNHG14|UBE3A	K304fs, K721fs, K284fs, K646fs, K724fs, K662fs, K701fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155966	15	25599792 - 25599793	15	25354645 - 25354646	155966	165770	rs587781215	NC_000015.10:25354645::AATA
NM_130839.5(UBE3A):c.2017dup (p.Met673fs)	SNHG14|UBE3A	M673fs, M676fs, M614fs, M236fs, M256fs, M653fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155963	15	25601145 - 25601146	15	25355998 - 25355999	155963	165767	rs587781212	NC_000015.10:25355998:T:TT
NM_130839.5(UBE3A):c.1699_1702dup (p.Ser568fs)	SNHG14|UBE3A	S571fs, S509fs, S151fs, S548fs, S131fs, S568fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155958	15	25605580 - 25605581	15	25360433 - 25360434	155958	165762	rs587781207	NC_000015.10:25360433:AAACA:AAACAAACA
NM_130839.5(UBE3A):c.1668dup (p.Glu557Ter)	SNHG14|UBE3A	E537*, E557*, E560*, E498*, E120*, E140*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155957	15	25605614 - 25605615	15	25360467 - 25360468	155957	165761	rs587781206	NC_000015.10:25360467:AAA:AAAA
NM_130839.5(UBE3A):c.1631dup (p.Asn544fs)	SNHG14|UBE3A	N107fs, N485fs, N127fs, N544fs, N547fs, N524fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155956	15	25605651 - 25605652	15	25360504 - 25360505	155956	165760	rs587781205	NC_000015.10:25360504:TTTT:TTTTT
NM_130839.5(UBE3A):c.1597dup (p.Ala533fs)	SNHG14|UBE3A	A474fs, A533fs, A536fs, A513fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000155955	15	25615723 - 25615724	15	25370576 - 25370577	155955	165759	rs587781204	NC_000015.10:25370576:C:CC
NM_130839.5(UBE3A):c.1415dup (p.Ser473fs)	SNHG14|UBE3A	S414fs, S473fs, S476fs, S453fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155950	15	25615905 - 25615906	15	25370758 - 25370759	155950	165754	rs587781199	NC_000015.10:25370758:AA:AAA
NM_130839.5(UBE3A):c.1136dup (p.Asn379fs)	SNHG14|UBE3A	N359fs, N379fs, N320fs, N382fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155945	15	25616184 - 25616185	15	25371037 - 25371038	155945	165749	rs587781194	NC_000015.10:25371037:TTT:TTTT
NM_130839.5(UBE3A):c.1127dup (p.Tyr376Ter)	SNHG14|UBE3A	Y317*, Y356*, Y376*, Y379*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155944	15	25616193 - 25616194	15	25371046 - 25371047	155944	165748	rs587781193	NC_000015.10:25371046:T:TT
NM_130839.5(UBE3A):c.640dup (p.Ser214fs)	SNHG14|UBE3A	S194fs, S217fs, S155fs, S214fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136196	15	25616680 - 25616681	15	25371533 - 25371534	136196	139900	rs587780574	NC_000015.10:25371533:T:TT
NM_130839.5(UBE3A):c.463dup (p.Ser155fs)	SNHG14|UBE3A	S155fs, S135fs, S158fs, S96fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136194	15	25616857 - 25616858	15	25371710 - 25371711	136194	139898	rs587780572	NC_000015.10:25371710:AAAAAA:AAAAAAA
NM_130839.5(UBE3A):c.335dup (p.Lys113fs)	SNHG14|UBE3A	K54fs, K116fs, K93fs, K113fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136190	15	25620637 - 25620638	15	25375490 - 25375491	136190	139894	rs587780568	NC_000015.10:25375490:TT:TTT
NM_130839.5(UBE3A):c.259_262dup (p.Gly88fs)	SNHG14|UBE3A	G68fs, G88fs, G91fs, G29fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136188	15	25620710 - 25620711	15	25375563 - 25375564	136188	139892	rs587780566	NC_000015.10:25375563:CTTTCTT:CTTTCTTTCTT
NM_001130438.3(SPTAN1):c.6592_6597dup (p.Leu2198_Gln2199dup)	SPTAN1		Early infantile epileptic encephalopathy 5	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666262	9	131389677 - 131389678	9	128627398 - 128627399	666262	653813	rs1589393179	NC_000009.12:128627398:AGCTGCAG:AGCTGCAGCTGCAG
NM_001083962.2(TCF4):c.1965dup (p.Gly656fs)	TCF4	G492fs, G581fs, G627fs, G632fs, G633fs, G655fs, G758fs, G491fs, G526fs, G628fs, G649fs, G522fs, G610fs, G614fs, G631fs, G652fs, G440fs, G496fs, G585fs, G651fs, G656fs, G662fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000212379	18	52895506 - 52895507	18	55228275 - 55228276	212379	208455	rs797046035	NC_000018.10:55228275:GG:GGG
NM_130839.5(UBE3A):c.2124+9_2124+10insTT	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001126495	15	25601029 - 25601030	15	25355882 - 25355883	1126495	1124155		NC_000015.10:25355882:A:AAA
NC_000015.9:g.(?_25584273)_(25650609_?)dup	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001075074	15	25584273 - 25650609			1075074	1057670		
NM_130839.5(UBE3A):c.2600_2604dup (p.Phe869fs)	UBE3A|SNHG14	F452fs, F797fs, F817fs, F869fs, F872fs, F794fs, F810fs, F849fs, F432fs	Angelman syndrome	Likely pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000961399	15	25584298 - 25584299	15	25339151 - 25339152	961399	948780		NC_000015.10:25339151:TCCTTT:TCCTTTCCTTT
NC_000015.10:g.(?_25339137)_(25405462_?)dup	UBE3A		Angelman syndrome	Likely pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000831131	15	25584284 - 25650609			831131	820669		
NC_000015.10:g.(?_25339117)_(25360547_?)dup	UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000830404	15	25584264 - 25605694			830404	820666		
NM_130839.5(UBE3A):c.2517_2553dup (p.Lys852delinsLeuLeuTer)	UBE3A|SNHG14		Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803055	15	25584349 - 25584350	15	25339202 - 25339203	803055	791432	rs1595362860	NC_000015.10:25339202:GCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAG:GCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAGCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAG
NM_130839.5(UBE3A):c.1541dup (p.Gln515fs)	UBE3A|SNHG14	Q518fs, Q456fs, Q495fs, Q515fs	not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000423094	15	25615779 - 25615780	15	25370632 - 25370633	423094	409192	rs1064796224	NC_000015.10:25370632:T:TT
NM_130839.5(UBE3A):c.1244_1253dup (p.Gly419fs)	UBE3A|SNHG14	G399fs, G422fs, G360fs, G419fs	Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000280389	15	25616067 - 25616068	15	25370920 - 25370921	280389	264716	rs886041603	NC_000015.10:25370920:TTCTTGTTTCTTCTT:TTCTTGTTTCTTCTTGTTTCTTCTT
UBE3A, 15-BP DEL/7-BP INS, NT3240	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030204					30204	39160		
UBE3A, 4-BP DUP, EX10, GAGG	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000007972					7972	23011		
UBE3A, 5-BP DUP	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007963					7963	23002		
NM_014795.4(ZEB2):c.876dup (p.Tyr293fs)	ZEB2	Y269fs, Y293fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001076838	2	145158805 - 145158806	2	144401238 - 144401239	1076838	1058920		NC_000002.12:144401238:TTT:TTTT
NM_014795.4(ZEB2):c.818_821dup (p.Gln275fs)	ZEB2	Q251fs, Q275fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001072214	2	145158860 - 145158861	2	144401293 - 144401294	1072214	1058922		NC_000002.12:144401293:GTTAG:GTTAGTTAG
NM_014795.4(ZEB2):c.1683_1689dup (p.Asp564fs)	ZEB2	D540fs, D564fs	Mowat-Wilson syndrome	Likely pathogenic	criteria provided, single submitter	VCV000974830	2	145157064 - 145157065	2	144399497 - 144399498	974830	963122		NC_000002.12:144399497:TATTAAA:TATTAAATATTAAA
NM_014795.4(ZEB2):c.776dup (p.His259fs)	ZEB2	H235fs, H259fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000935642	2	145161513 - 145161514	2	144403946 - 144403947	935642	930804		NC_000002.12:144403946:T:TT
NM_014795.4(ZEB2):c.2619_2620delinsAT (p.Asn873_Asn874delinsLysTyr)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000848011	2	145156134 - 145156135	2	144398567 - 144398568	848011	824764		NC_000002.12:144398566:TA:AT
NM_014795.4(ZEB2):c.432dup (p.Glu145Ter)	ZEB2	E145*, E121*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000572710	2	145162562 - 145162563	2	144404995 - 144404996	572710	557524	rs1560609810	NC_000002.12:144404995:AAAA:AAAAA
NM_014795.4(ZEB2):c.1570dup (p.Ser524fs)	ZEB2	S524fs, S500fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000571056	2	145157183 - 145157184	2	144399616 - 144399617	571056	558725	rs1560606974	NC_000002.12:144399616:TTTT:TTTTT
NM_014795.4(ZEB2):c.71dup (p.Asn24fs)	ZEB2	N24fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	no assertion criteria provided	VCV000559637	2	145274846 - 145274847	2	144517279 - 144517280	559637	550349	rs1553971826	NC_000002.12:144517279:TTTTT:TTTTTT
NM_014795.4(ZEB2):c.247dup (p.Glu83fs)	ZEB2	E83fs	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547832	2	145187419 - 145187420	2	144429852 - 144429853	547832	537695	rs1553964145	NC_000002.12:144429852:CC:CCC
NM_014795.4(ZEB2):c.2688dup (p.Ala897fs)	ZEB2	A873fs, A897fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000466281	2	145156065 - 145156066	2	144398498 - 144398499	466281	448708	rs1553961510	NC_000002.12:144398498:T:TT
NM_014795.4(ZEB2):c.2038_2152dup (p.Asn718delinsSerCysGlyProSerSerGlyIleCysGluGlyMetValTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000466279	2	145156601 - 145156602	2	144399034 - 144399035	466279	448705	rs1553961598	
NM_014795.4(ZEB2):c.2211_2214dup (p.Ile739fs)	ZEB2	I715fs, I739fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000448970	2	145156539 - 145156540	2	144398972 - 144398973	448970	442547	rs1553961585	NC_000002.12:144398972:GGAG:GGAGGGAG
NM_014795.4(ZEB2):c.593-18_593-17insTG	ZEB2		not specified|Mowat-Wilson syndrome	Benign(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418552	2	145161714 - 145161715	2	144404147 - 144404148	418552	405296	rs776927209	NC_000002.12:144404147:A:ACA
NM_014795.4(ZEB2):c.2205_2206delinsCG (p.Met736Val)	ZEB2	M712V, M736V	Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000405332	2	145156548 - 145156549	2	144398981 - 144398982	405332	391604	rs1060500654	NC_000002.12:144398980:TA:CG
NM_014795.4(ZEB2):c.*35dup	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331297	2	145146982 - 145146983	2	144389415 - 144389416	331297	282627	rs567229506	NC_000002.12:144389415:AAAAAAAAA:AAAAAAAAAA
NM_014795.4(ZEB2):c.*514dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331291	2	145146503 - 145146504	2	144388936 - 144388937	331291	281983	rs558553086	NC_000002.12:144388936:AAAAAAAAAA:AAAAAAAAAAA
NM_014795.4(ZEB2):c.*560dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331289	2	145146457 - 145146458	2	144388890 - 144388891	331289	281976	rs533637050	NC_000002.12:144388890:AAAAAAAAAAAAA:AAAAAAAAAAAAAA
NM_014795.4(ZEB2):c.*1796dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331278	2	145145221 - 145145222	2	144387654 - 144387655	331278	282607	rs886054890	NC_000002.12:144387654:TTTTTTTT:TTTTTTTTT
NM_014795.4(ZEB2):c.*2396_*2397insGT	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331263	2	145144621 - 145144622	2	144387054 - 144387055	331263	284272	rs886054883	NC_000002.12:144387054:A:ACA
NM_014795.4(ZEB2):c.*2525dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331256	2	145144492 - 145144493	2	144386925 - 144386926	331256	284268	rs886054882	NC_000002.12:144386925:CCCCCCCC:CCCCCCCCC
NM_014795.4(ZEB2):c.*4844_*4845dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331229	2	145142172 - 145142173	2	144384605 - 144384606	331229	284214	rs201661554	NC_000002.12:144384605:TTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_014795.4(ZEB2):c.*4845dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331228	2	145142172 - 145142173	2	144384605 - 144384606	331228	282545	rs201661554	NC_000002.12:144384605:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_014795.4(ZEB2):c.1541_1542insA (p.Val515fs)	ZEB2	V515fs, V491fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189271	2	145157212 - 145157213	2	144399645 - 144399646	189271	187161	rs1553961695	NC_000002.12:144399645::T
NM_014795.4(ZEB2):c.1172_1182delinsTGACTTAAAATTAATG (p.Lys391_Pro394delinsMetThrTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189267	2	145157572 - 145157582	2	144400005 - 144400015	189267	187165	rs786204805	NC_000002.12:144400004:TGGTTCTGTTT:CATTAATTTTAAGTCA
NM_014795.4(ZEB2):c.20_21insT (p.Asp8fs)	ZEB2	D8fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189264	2	145274897 - 145274898	2	144517330 - 144517331	189264	187172	rs786204802	NC_000002.12:144517330::A
NM_014795.4(ZEB2):c.178_190delinsGTT (p.Thr60fs)	ZEB2	T60fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	VCV000181758	2	145187477 - 145187489	2	144429910 - 144429922	181758	179008	rs730881215	NC_000002.12:144429909:TAGCTGGACTCGT:AAC
NM_014795.4(ZEB2):c.3195dup (p.His1066fs)	ZEB2	H1042fs, H1066fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	VCV000181756	2	145147467 - 145147468	2	144389900 - 144389901	181756	178965	rs730881213	NC_000002.12:144389900:T:TT
NM_014795.4(ZEB2):c.3359_3364delinsTAATG (p.Gly1120fs)	ZEB2	G1096fs, G1120fs	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 25, 2013)	criteria provided, single submitter	VCV000095635	2	145147299 - 145147304	2	144389732 - 144389737	95635	101533	rs398124280	NC_000002.12:144389731:AGTACC:CATTA
NM_014795.4(ZEB2):c.3566_3567dup (p.Met1190fs)	ZEB2	M1166fs, M1190fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004763	2	145147095 - 145147096	2	144389528 - 144389529	4763	19802	rs587776609	NC_000002.12:144389528:GG:GGGG
NM_014795.4(ZEB2):c.2453dup (p.Leu818fs)	ZEB2	L794fs, L818fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004759	2	145156300 - 145156301	2	144398733 - 144398734	4759	19798	rs587776606	NC_000002.12:144398733:AA:AAA
NM_014795.4(ZEB2):c.760_761dup (p.Gln255fs)	ZEB2	Q231fs, Q255fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004758	2	145161528 - 145161529	2	144403961 - 144403962	4758	19797	rs587776605	NC_000002.12:144403961:GTG:GTGTG
NM_014795.4(ZEB2):c.1426dup (p.Met476fs)	ZEB2	M476fs, M452fs	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004757	2	145157327 - 145157328	2	144399760 - 144399761	4757	19796	rs587776604	NC_000002.12:144399760:TTTTTT:TTTTTTT
